Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67%
11:35am, Friday, 12'th Apr 2024
AbbVie's stock has outperformed the market over the past decade, with a 248.90% appreciation. Despite losing patent protection for Humira, which accounted for 37% of revenue in 2022, AbbVie remains un
AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
06:51pm, Thursday, 11'th Apr 2024
The latest trading day saw AbbVie (ABBV) settling at $167.52, representing a -0.89% change from its previous close.
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
01:10pm, Thursday, 11'th Apr 2024
Biotech stocks were among the worst performers in 2023. And so far in 2024, investors are still waiting on the recovery rally.
Are You Looking for a High-Growth Dividend Stock?
12:46pm, Wednesday, 10'th Apr 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
04:21am, Tuesday, 09'th Apr 2024
AbbVie's dividend payout has more than tripled over the past decade, and it could soar much further in the decade ahead. Bristol Myers Squibb offers a juicy 4.7% dividend yield at recent prices.
Here's Why AbbVie (ABBV) Fell More Than Broader Market
06:56pm, Monday, 08'th Apr 2024
In the latest trading session, AbbVie (ABBV) closed at $169.80, marking a -0.12% move from the previous day.
AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision
11:25am, Monday, 08'th Apr 2024
AbbVie's stock price fell by about 7% last week after the company revised its full-year and Q1 guidance downward.
Is Johnson & Johnson Stock A Better Pick Over AbbVie?
07:30am, Monday, 08'th Apr 2024
We believe that the pharmaceuticals bellwether Johnson & Johnson (NYSE: JNJ) is currently a better pick over its peer AbbVie (NYSE: ABBV). AbbVie ABBV trades at a higher valuation of 5.5x trailing rev
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Friday, 05'th Apr 2024
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year
09:28am, Thursday, 04'th Apr 2024
The topic of passive income is popular these days. Investors, consumers, and many other individuals are curious about any method that can produce income without work.
2 Strong Dividend Buys And 2 Sells For Q2 2024
10:13am, Wednesday, 03'rd Apr 2024
I present you our framework for buying and selling dividend stocks. It follows our simple motto of buy low, sell high, get paid to wait. Here are 2 brilliant buys and 2 smart sells for Q2 2024.
The 3 Best Stocks to Buy in April 2024
03:24pm, Tuesday, 02'nd Apr 2024
The big money might be feeling a bit queasy about overexposure to risk-on assets, presenting a framework to follow regarding the best stocks to buy in April. As I've mentioned many times before, techn
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:51pm, Monday, 01'st Apr 2024
The latest trading day saw AbbVie (ABBV) settling at $180.76, representing a -0.74% change from its previous close.
10 Dividend Growth Stocks: March 2024
03:44am, Monday, 01'st Apr 2024
10 Dividend Growth Stocks: March 2024
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
05:19am, Saturday, 30'th Mar 2024
Now that it's focused on just medical technology and pharmaceuticals, Johnson & Johnson's pace of annual dividend raises could accelerate. Medtronic is the largest publicly traded medical device manuf
